274 related articles for article (PubMed ID: 8733795)
1. Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine.
Litman RE; Su TP; Potter WZ; Hong WW; Pickar D
Br J Psychiatry; 1996 May; 168(5):571-9. PubMed ID: 8733795
[TBL] [Abstract][Full Text] [Related]
2. Idazoxan, an alpha 2 antagonist, augments fluphenazine in schizophrenic patients: a pilot study.
Litman RE; Hong WW; Weissman EM; Su TP; Potter WZ; Pickar D
J Clin Psychopharmacol; 1993 Aug; 13(4):264-7. PubMed ID: 8104200
[TBL] [Abstract][Full Text] [Related]
3. Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia.
Owen RR; Gutierrez-Esteinou R; Hsiao J; Hadd K; Benkelfat C; Lawlor BA; Murphy DL; Pickar D
Arch Gen Psychiatry; 1993 Aug; 50(8):636-44. PubMed ID: 8343034
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive loxapine in a clozapine-resistant cohort of schizophrenic patients.
Mowerman S; Siris SG
Ann Clin Psychiatry; 1996 Dec; 8(4):193-7. PubMed ID: 8986313
[TBL] [Abstract][Full Text] [Related]
5. Augmenting clozapine with sertindole: a double-blind, randomized, placebo-controlled study.
Nielsen J; Emborg C; Gydesen S; Dybbro J; Aagaard J; Haderup K; Glyngdal P; Fabricius S; Thode D; Lublin H; Andersen T; Damkier P; Taylor D
J Clin Psychopharmacol; 2012 Apr; 32(2):173-8. PubMed ID: 22367659
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia.
Meltzer HY; Bobo WV; Lee MA; Cola P; Jayathilake K
Psychiatry Res; 2010 May; 177(3):286-93. PubMed ID: 20378185
[TBL] [Abstract][Full Text] [Related]
7. Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine.
Pickar D; Owen RR; Litman RE; Konicki E; Gutierrez R; Rapaport MH
Arch Gen Psychiatry; 1992 May; 49(5):345-53. PubMed ID: 1375019
[TBL] [Abstract][Full Text] [Related]
8. Clinical response to clozapine in patients with schizophrenia.
Pickar D; Litman RE; Hong WW; Su TP; Weissman EM; Hsiao JK; Potter WZ
Arch Gen Psychiatry; 1994 Feb; 51(2):159-60. PubMed ID: 8297214
[No Abstract] [Full Text] [Related]
9. Effects of clozapine on cognitive function in schizophrenia.
Lee MA; Thompson PA; Meltzer HY
J Clin Psychiatry; 1994 Sep; 55 Suppl B():82-7. PubMed ID: 7961582
[TBL] [Abstract][Full Text] [Related]
10. [Sequence in prescribing neuroleptics: a therapeutic alternative in refractory schizophrenia?].
Allouche G; Joober R; Vanelle JM; Brochier T; Olié JP
Encephale; 1994; 20(6):777-80. PubMed ID: 7875112
[TBL] [Abstract][Full Text] [Related]
11. A double-blind comparative study of clozapine versus chlorpromazine on Chinese patients with treatment-refractory schizophrenia.
Hong CJ; Chen JY; Chiu HJ; Sim CB
Int Clin Psychopharmacol; 1997 May; 12(3):123-30. PubMed ID: 9248867
[TBL] [Abstract][Full Text] [Related]
12. Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison.
Kumra S; Kranzler H; Gerbino-Rosen G; Kester HM; De Thomas C; Kafantaris V; Correll CU; Kane JM
Biol Psychiatry; 2008 Mar; 63(5):524-9. PubMed ID: 17651705
[TBL] [Abstract][Full Text] [Related]
13. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response.
Breier AF; Malhotra AK; Su TP; Pinals DA; Elman I; Adler CM; Lafargue RT; Clifton A; Pickar D
Am J Psychiatry; 1999 Feb; 156(2):294-8. PubMed ID: 9989566
[TBL] [Abstract][Full Text] [Related]
14. Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia.
Breier A; Buchanan RW; Kirkpatrick B; Davis OR; Irish D; Summerfelt A; Carpenter WT
Am J Psychiatry; 1994 Jan; 151(1):20-6. PubMed ID: 8267129
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia.
Lee MA; Jayathilake K; Meltzer HY
Schizophr Res; 1999 May; 37(1):1-11. PubMed ID: 10227103
[TBL] [Abstract][Full Text] [Related]
16. The effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled study.
Zoccali R; Muscatello MR; Cedro C; Neri P; La Torre D; Spina E; Di Rosa AE; Meduri M
Int Clin Psychopharmacol; 2004 Mar; 19(2):71-6. PubMed ID: 15076014
[TBL] [Abstract][Full Text] [Related]
17. Effects of switching inpatients with treatment-resistant schizophrenia from clozapine to risperidone.
Still DJ; Dorson PG; Crismon ML; Pousson C
Psychiatr Serv; 1996 Dec; 47(12):1382-4. PubMed ID: 9117479
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.
Chakos M; Lieberman J; Hoffman E; Bradford D; Sheitman B
Am J Psychiatry; 2001 Apr; 158(4):518-26. PubMed ID: 11282684
[TBL] [Abstract][Full Text] [Related]
19. The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients: a double-blind, placebo-controlled study.
Zoccali R; Muscatello MR; Bruno A; Cambria R; Micò U; Spina E; Meduri M
Schizophr Res; 2007 Jul; 93(1-3):109-16. PubMed ID: 17383857
[TBL] [Abstract][Full Text] [Related]
20. Clozapine: current status and role in the pharmacotherapy of schizophrenia.
Remington GJ; Addington D; Collins EJ; Jones BD; Lalonde P; MacCrimmon DJ; MacEwan GW
Can J Psychiatry; 1996 Apr; 41(3):161-6. PubMed ID: 8722645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
